|  Fertility NEWS LETTER Ideal fertility : ICSI / IVF & Genetic Center India 
                          
                            | Vol VIII,issue 4, April 2010 
 In this issue
 
                                Clomiphene citrate : some useful pointsGnRh antagonist regimen in IUI and IVFFellowship course in Reproductive  endocrinology and Infertility In previous issue 
                                Lady with Australia       antigen +ve carrying  2 month       pregnancyWe did a cordocentesisCompare Rh Neg, non       sensitized and sensitized pregnancy |  Dear CollegesHello
 
 In this month we have our journal club and a young  gynecologist of the city Dr.Anupama Solonki presented her topic on “ steroid  synthesis and Two cell-two gonadotropin theory” . It was very basic in  reproductive endocrinology and with new facts of paracrine and autocrine  actions of various cytokines.
                           In the same context I presented one topic on clinical  correlation of this theory in ovulation induction and ovarian stimulation.Various facts of different drugs were discussed.
                           In this news letter I took two drugs ,which I found of  interest ,one is clomiphene citrate and the other is GnRh antagonist.                           I am really touched by the response I am getting for this  news letter, I request you all to contribute in this endeavor to bring new  clinical facts to our colleagues.
 With best wishes
 Dr. D’Pankar Banerji
 1.Clomiphene citrate: Some useful points Clomiphene acts as a competitive antagonist of 17beta  estradiol at the level of the cytoplasmic nuclear receptor complexes in the hypothalamus,  pituitary and elsewhere. Blockade of E2 receptor at eh level of  hypothalamus leads to increase in gonadotropin –releasing hormone (GnRh) and to  an increase in LH and presumably FSH.                           FSH and LH rise is increased to 3-4 fold.                           It requires an intact hypothalamus-pituitary-ovarian axis an  destrogen                           Due to its site of action the dose should be taken in one  time to optimize its entry into hypothalamus.                           After administration : A stedt state approximately 25%,of  peak concentration is reached at 48 hrs. and remains constant fprthe next 14  days                           Dose of clomiphene necessary to induce ovulation or increase  luteal phase progesterone os proportional to body weight                           The effect of repeated administration of a single 50mg  tablet at 28 days interval is cumulative,wit basal level of zu-clomiphene  omcreasing by 50% per month. Owing to the accumulation of zuclomiphene,  clomiphene may be more effective in inducing ovulation during the second and  later cycles of treatnment, even though the dose administered remains the same.                           After ovulation induction with clomiphene, serum  progesterone and estradiol serum levels are increasd during the luteal ppase of  the cycle in a direct dose –response relationship.                           Clomiphene citrate I given for 5 days,beginning from day 3-  day5                           Clomiphene is ineffective if started too soon,before  estradiol level are 45-60 pg/ml. Follicles are 6 mm or greater when estradiol  is in this range.                           Starting dose should not be greater than 50 mg when weight  is around 50 kg and should not be more than 100mg when around 75 kg.                           Test required before starting clomiphene :                            Ultrasound: Clomiphene should not be sarted if the  endometrial lining is more than 6 mm,follicular response will be poor. It  should be done to rule out any persistand corpus luteum,ovarian  neoplasm,endometriosis and antral follicle count.                           Ovarian cysts: cysts larger than 4 cm should be explored  surgically,not drained. Smaller cyst without cancer chareacteristics of wall  thickness 3 mm or greater or inclusions may either be followed until they  resolve or suppressed with oral contraceptives.Progesterone alone is  ineffective, and GnRh agonists may cause functional cysts to grow larger.                            E2 and Progesterone : E2 > 45-60 pg/ml ,clomiphene will  be effective. Raised progesterone will tell whether retension cyst is active or  not. Before deciding that a patient is clomiphene resistant,E2 level should me  measured on the customary start day to determine if clomiphene has been started  too soon.                           Monitoring :                            Follicular development : In clomiphene cycle, the lead  follicle is usually 20-24 mm the day ovulation and 18-20 mm the day of  spontaneous LH surge.highest pregnancy rates occur when there are four  follicles 15 mm or larger ad are not increased when five or more follicles.when  HCG is used to trigger ovulation, highest pregnancy rates are achieved when the  lead follicle is 16 mm.                           Endometrial thickness : It should be at least 6 mm and  preferably 9 mm or greater on preovulatory ultrasound. Endometrial thickness  increases at a faster rate in clomiphene cycles than in spontaneous cycles  durig the late proliferative phase as it escapes from antiestrogen effect of  clomiphene.                           Serum or urine LH : an increase in serum LH twice Vaseline  level predicts ovulation within 24 hrs and urine LH predicts ovulation within  12 hrs.                           Progesterone : It is used to confirm ovulation to determine  if the dose of clomiphene is sufficient. It should be measured in midluteal  phase5-7 days after ovulation,to conside with the day embryo inplantation.  Progesterone levels in th midluteal phase of clomiphene cycles that result in  term pregnancies average 37 pg/ml,compared to 22 pg/ml in spontaneous cycles.  If it is found less in luteal phase then additional progesterone should be  given to increase it above 20 pg/ml.                           Intra-uterine insemination : IUI should be considered fpr  women whose partner’s sperm only meets minimal standards for normal as well as  women who have mucus abnormalities.                           Unexplained infertility : use of clomiphene to increase pre-ovulation  estrogen level and  post ovulation  progesterone levels, alone or combined with IUI has been shown to be an  effective first-line treatment for “unexplained infertility”. Diagnosis of  luteal insufficiency can be missed if it is assumed that a progesterone level  of 5 pg/ml is normal. In fact it should be more than 15 pg/ml.                             How many cycles of clomiphene should be performed:  cumulative pregnancy rates after six cycles of clomiphene IUI reached 75% in  women receiving donor semen and 65% in women treated with clomiphene for  ovulatory dysfunction if they ere younger than forty two yrs, used sperm of  satisfactory quality and did not have endometriosis or tubal factor 2.  SUMMER COURSE PROGRAM  In Medical Biotechnology  7th June 2010 - 17th June2010Time 8.00am-1.00pm
 Program : Day  1 Theory : 
                          Introduction to cell biologyMicroscopy                           Practical : Microscopy  :Stereozoom, Trinocular photomicrography, Inverted Microscopy
 Day  2 Theory
                         
                            Practical :Cell cycle and cell divisionPrimary tissue culture,  introduction to tissue culture Culture media  preparation for tissue culture
 Day  3 Theory 
                          Detection and       measurement of genetic variationMonohybrid/dihybrid,       mutations, Mendelian genetics Practical : Planting
 Day  4 Theory : 
                          Replicationranscription and translation                         Practical : DNA isolation from  blood
 Day5  Theory 
                          ovulation induction for       in vitro fertilizationHuman ,genetic diseases                            Practical : PCR demonstration
 Day6 Theory : Embryo biotechnology and  stem cells
  Practical: 
                          Hands on retrieval of mammalian  eggs under stereomicroscope                            in-vitro maturation of oocyte Day7 Practical:Harvesting of culture
 In-vitro maturation of oocytes
 Day8 Theory : Single Gene disorders
  Practical:Cryopreservation of  Spermatozoa and oocytes
 Day9 Theory : Immunogenetics,basic
  Practical:Banding / slide preparation /identification of chromosomes  harvested earlier
 Day10 Seminar by the participantsCertificate distribution
 Faculty :1. Dr.D'Pankar Banerji, Gynecologist and  Infertility specialist
 2. Dr. Mrs. Rinku Banerji ,Pathologist and  Embryologist
 Fees : Rs.5000.00Phone Number to contact : 2627711
 Stay  can be arranged at nearby hotels at a reasonable rates at an extra cost
 
                          
                            
                              | Archives |  
                              | 
                                Vol VIII, Issue 11, Nov   2010 Vol VIII, issue 6, June,2010Vol VIII,issue 5, May 2010Vol VIII,issue 4, April 2010Vol VIII Issue 3, March 2010Vol VIII, Issue 1,Jan 2010Vol VII, Issue 12,Dec.2009Vol VII, Issue 11,Nov.2009Vol VII, Issue 10,Oct.2009Vol VII, Issue 9, Sep.2009Vol VII, Issue 8, Aug 2009Vol VII, Issue 7,July 2009Vol VII, Issue 6,June 2009Vol VII Issue 4 april 2009Vol VI, Issue 9, Sep 2008 Vol   Vi Issue 8, aug 2008 Vol Vi Issue 7, july   2008  Vol VI, Issue 6, June   2008 Vol V, Issue 17, may   2008  | 
                                Vol IV, Issue 16, April   2008 Vol III, Issue 15, March   2008  Vol I & II, Issue   13-14, Jan Feb 2008 Vol IV, Issue 12, December   2007 Vol IV, Issue 11, November   2007Vol IV, Issue 10,   October 2007Vol IV, Issue 9,   September 2007Vol IV, Issue 8,   August 2007  Vol IV, Issue 7, July   2007 Vol IV, Issue 6, June   2007 Vol IV, Issue 5, May   2007 Vol IV, Issue 4, April   2007 Vol IV, Issue 3, March   2007  Vol IV, Issue 2,   FEB_2007 Vol IV, Issue1, Jan 2007 Vol III, Issue 9,   Nov Dec 2006Vol II, issue7, July 2005Vol II, Issue4 April 2005Vol II, Issue3, March 2005 |  
 |